BullFrog AI Holdings (BFRGW) Convertible Debt (2022)
BullFrog AI Holdings' (BFRGW) quarterly Convertible Debt came in at $1.0 million in Q4 2022.
Analysis
BullFrog AI Holdings (BFRGW) Convertible Debt (2022) Analysis & Trends
BullFrog AI Holdings (BFRGW) has reported Convertible Debt for 1 consecutive years, with $1.0 million the latest figure, recorded in Q4 2022.
- For the quarter ending Q4 2022, Convertible Debt changed N/A year-over-year to $1.0 million; the trailing twelve-month figure through Dec 2022 stood at $1.0 million (changed N/A YoY), and the FY2022 full-year result was $1.0 million, changed N/A from the prior year.
- Convertible Debt steadied at $1.0 million in Q4 2022 per BFRGW's latest filing.
- Across five years, Convertible Debt topped out at $1.0 million in Q4 2022 and bottomed at $1.0 million in Q4 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 210.86 Bn | 196.87 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 181.23 Bn | 178.05 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 132.14 Bn | 124.29 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 82.88 Bn | 74.88 Bn | 3.93 Bn |
| 5 | Argenx Se | 61.72 Bn | 56.54 Bn | 1.37 Bn |
| 6 | Moderna | 54.82 Bn | 49.68 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.09 Bn | 30.79 Bn | 992.69 Mn |
| 8 | Biogen | 31.28 Bn | 29.99 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 30.40 Bn | 30.40 Bn | 1.16 Mn |
| 10 | BullFrog AI Holdings | 1.84 Mn | -5.08 Mn | 106,899.00 |